-+ 0.00%
-+ 0.00%
-+ 0.00%

Syndax Pharmaceuticals' clinical trial for idiopathic pulmonary fibrosis failed, and the stock price plummeted 34% after the market.

Zhitongcaijing·10/12/2026 20:09:02
Listen to the news
Syndax Pharmaceuticals' clinical trial for idiopathic pulmonary fibrosis failed, and the stock price plummeted 34% after the market.